Stephen E.F. Spurgeon, M.D.

Academic and Clinical Position

Assistant Professor

Biography

Dr. Spurgeon provides expertise in lymphoid malignancies. He often works with referring oncologists to develop treatment plans that can be effectively delivered in the community. He is also involved in a number of multicenter and investigator studies, including early phase studies for relapsed patients, especially in chronic lymphocytic leukemia. He collaborates with the OHSU Knight Cancer Institute's Center for Cell Signaling, evaluating signaling pathways and exploring the effects of new drugs on patient cancer samples, e.g., lymph nodes, bone marrow and peripheral blood. 

Dr. Spurgeon is a member of the multi-disciplinary lymphoid malignancies team that reviews each patient's ongoing management plan. All new and/or complicated lymphoid malignancy cases are reviewed by the multidisciplinary lymphoid malignancy tumor board. Dr. Spurgeon believes collaborations with colleagues within the OHSU Knight Cancer Institute, across the Northwest and around the country are essential, allowing patients access to unique therapeutic and research opportunities as well as to other experts in the field.

Dr. Spurgeon participates regularly in medical school, patient, and physician education programs. He also sits on the OHSU Knight Cancer Institute scientific review committee.

Professional Education

• Degree:
  M.D., Jefferson Medical College at Thomas Jefferson University, Philadelphia, PA, 2002
  
• Residency:
  2002-2005. Residency: Oregon Health & Science University; Portland, Oregon
  2005-2006. Chief Resident: Oregon Health & Science University; Portland, Oregon
• Fellowship:
  2006-2009. Fellowship: Oregon Health & Science University; Portland, Oregon

Certifications

• Certifications:
  American Board of Internal Medicine (Internal Medicine), 2005
  American Board of Internal Medicine (Hematology), 2009
  American Board of Internal Medicine (Medical Oncology), 2009

Memberships and Associations

American Society of Oncology
American Society of Hematology
Southwest Oncology Group
Alpha Omega Alpha

Additional Information

Knight Cancer Institute Clinical Research Review Committee (CRRC) Member Guest Lecturer Leukemia and Lymphoma Society

Research Interests:

Chronic lymphocytic leukemia, indolent lymphoma, intermediate and high-risk lymphoma, B-cell signaling, novel therapeutic targets, clinical trials